View more on these topics

Teather & Greenwood appoints pharms analyst

Teather & Greenwood is appointing Stephen Waterman as pharmaceuticals and biotechnology analyst, teaming up with existing analyst Howard Miller.

Waterman joins after three years with pharmaceutical database provider Evaluate Pharma, where he was senior pharmaceuticals and biotechnology analyst, prior to which he obtained a Ph.D in Neuropharmacology at Cambridge University.

Teather & Greenwood head of research Michael Drozd says: "He has considerable experience of the sector and will make a significant contribution as we develop our corporate and institutional business in this area."


Misys deal could face probe over competition

The Misys deal may face investigation by the competition authorities depen-ding on how the Office of Fair Trading defines market share.Misys is referring the DBS deal to the OFT this week and is confident it will pass the competition regulations. But investigations by the OFT and possible further action will depend on how the OFT […]

Mimi offers protection

Mitchell says: “The product is well suited for many clients who require protection in connection with a mortgage. The policy can also be used for family protection and also business purposes, although it is not marketed as such.”On the subject of the marketing opportunities that the plan will provide, Miles cannot see any, Mitchell says: […]

The national wealth service

Wealth has a habit of concentrating itself in the hands of the few – and IFAs want those hands to be their own.Targeting the high-net-worth market is seen as an attractive survival strategy for IFAs. Not only IFAs, but the banks have been seeking to bolster profit margins by focusing on the rich too.Wealth management […]

Robert Reid

Oh no, not another worthy eulogising the benefits of a move to thesupposed higher moral ground, I hear you say. But don&#39t worry, I amdetermined to look at the positive aspects of running your business on any method of remuneration and, more important, running it at a profit. Over the years I have attended many […]

Rayner Spencer Mills: Why we rate the Artemis US Select Fund

Ken Rayner and Graham O¹Neill from RSM explain why they rate the fund, its investment process and how it can be used in a portfolio The Artemis US Select Fund became a RSM ‘rated’ fund earlier this year. In this video, Ken Rayner and Graham O’Neill explain the fund’s investment approach, why they rate it, […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm